The educator Abdullah Abu Zayed stated that “Okaz” is not absent from the Diwaniyat al-Asdiqa’ in Al-Wajh Governorate, pointing out that they are keen to have it available daily in their council, before any other publication, because of the useful and interesting topics, reports and investigations it contains, committed to credibility and accuracy, as well as following it up. behind the news.
Read next
Health
GLP-1 Supply Expansion Drives Cost Reductions in Pharmaceutical Logistics
Scales of economy and improved cold-chain capacity are lowering production costs for next-generation metabolic drugs.
Health
GLP-1 Class Drugs Expand into Cardiovascular and Metabolic Therapies
Clinical trial outcomes prompt pharmaceutical re-allocation toward broader systemic disease management.
Health
GLP-1 Class Therapies Alter Pharmaceutical Capital Allocation
Surging demand for metabolic treatments is redirecting R&D expenditures away from traditional cardiovascular research.
Health
GLP-1 Class Drugs Drive Restructuring in Food and Healthcare Sectors
Widespread adoption of metabolic therapeutics reshapes consumer demand patterns and healthcare expenditure.
Health
Pharmaceutical Supply Chains Expand API Capacity for Metabolic Drugs
Active pharmaceutical ingredient manufacturers invest in continuous manufacturing to resolve global GLP-1 shortages.
Health
GLP-1 Supply Pressures Trigger Expansion in Synthetic Manufacturing Capacity
Pharmaceutical majors invest heavily in localized fill-finish infrastructure to clear global production backlogs.